Keyphrases
COVID-19
100%
Comorbidity
99%
Asthma
73%
Population-based
62%
Primary Care
61%
Scotland
56%
Confidence Interval
41%
Spain
37%
Meta-analysis
37%
Cardiovascular Disease
34%
Germany
33%
Chronic Obstructive Pulmonary Disease
32%
Older People
32%
Nested Case-control Study
31%
Type 2 Diabetes Mellitus (T2DM)
30%
External Validation
30%
Electronic Health Records
29%
Hospitalization
29%
Interrupted Time Series Regression
28%
South Korea
28%
Population Cohort Study
27%
Multinational Network
27%
Hazard Ratio
27%
Acute Kidney Injury
27%
Fluoroquinolones
27%
Competing Risks
25%
COVID-19 Pandemic
24%
Incidence Rate
24%
Time Series Regression Analysis
24%
France
23%
Beta-blockers
23%
International Networks
23%
Risk Prediction Tool
22%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
22%
COVID-19 Patients
22%
Retrospective Cohort Study
21%
Influenza
21%
Label Change
20%
Cardiovascular Risk Prediction
20%
Chronic Obstructive Pulmonary Disease Patient
20%
Performance Prediction
20%
Sectional Analysis
20%
Methodological Considerations
20%
Respiratory Effects
20%
People with Dementia
20%
Interrupted Time Series
20%
Antihyperglycemic
20%
Clinical Practice Research Datalink
20%
Netherlands
20%
Europe
19%
Medicine and Dentistry
COVID-19
92%
Cohort Analysis
73%
Primary Health Care
55%
Comorbidity
53%
Cardiovascular Disease
43%
Medicine
38%
Cohort Effect
35%
Maturity Onset Diabetes of the Young
29%
Cardiovascular System
28%
Systematic Review
27%
Electronic Health Record
27%
Cross Sectional Study
26%
Disease
26%
Time Series Analysis
26%
Multiple Chronic Conditions
25%
Randomized Controlled Trial
24%
Cardiovascular Risk
22%
Drug Therapy
22%
Acute Kidney Injury
22%
Opiate
22%
Observational Study
21%
Odds Ratio
18%
Prevalence
18%
Chronic Obstructive Pulmonary Disease
16%
Hazard Ratio
16%
Apoplexy
16%
Pharmacovigilance
16%
Thrombosis
15%
Thrombocytopenia
14%
Symptomatic Treatment
13%
Clinical Population
13%
Human Immunodeficiency Virus
13%
Hip Fracture
13%
Fragility Fracture
13%
Pancreas Cancer
13%
Population
13%
Antidepressant
13%
Sulfonylurea
13%
Glycon
12%
Meta-Analysis
12%
Malignant Neoplasm
11%
Adverse Event
11%
General Medicine
11%
Glucagon-Like Peptide-1 Agonist
10%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Decision Making
10%
Asthma
10%
Incentive
10%
Diuretic Agent
10%
Clinical Guideline
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
94%
Disease
61%
Asthma
58%
Cardiovascular Disease
38%
Coronavirinae
37%
Comorbidity
33%
Prevalence
30%
Quinolone Derivative
30%
Case-Control Study
29%
Randomized Controlled Trial
28%
Observational Study
28%
Pharmacovigilance
27%
Chronic Obstructive Lung Disease
25%
Acute Kidney Failure
25%
Non Insulin Dependent Diabetes Mellitus
25%
Fragility Fracture
20%
Beta Adrenergic Receptor Blocking Agent
20%
Antipsychotic
20%
Epidemiology
20%
Antidepressant
20%
Adverse Event
20%
Thrombosis
18%
Multiple Chronic Conditions
17%
Opiate
16%
Cross-Sectional Study
15%
Antibiotics
15%
Hydroxychloroquine
14%
Thrombocytopenia
14%
Dipeptidyl Carboxypeptidase Inhibitor
13%
Drug Utilization
13%
Risk Communication
13%
Tendon Rupture
13%
Hip Fracture
13%
Diclofenac
13%
Drug Development
13%
Bisphosphonic Acid Derivative
12%
Cerebrovascular Accident
12%
Monotherapy
12%
SARS Coronavirus
12%
Sulfonylurea
12%
Azithromycin
11%
Pandemic
11%
Typical Antipsychotic
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Diuretic Agent
10%
Infection
10%
COVID-19 Vaccine
10%
Kidney Disease
9%
Drug Safety
9%
Analgesic Agent
9%